Intramedullary Nailing System Provides Strong, Stable and Efficient Tool Designed to Promote Accurate Nail Insertion

Stryker’s Trauma & Extremities division today announced the launch of its T2^® ICF Intramedullary nailing system, offering a solution for patients suffering from serious foot conditions such as Charcot foot—a condition associated with diabetes resulting in poor bone quality, possible nerve damage and potential foot ulcers.¹

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005233/en/

Stryker’s new T2® ICF Intramedullary nailing system offers solution for patients suffering from serious foot conditions such as Charcot foot—a condition associated with diabetes. (Graphic: Business Wire)

The T2 ICF system is a stable product that provides a surgical option designed to prevent nail back out and promote fixation and accuracy. It is estimated that a leg is amputated every 30 seconds globally, and 85% of these amputations are the result of diabetic foot ulcers.²